ATE423139T1 - Natriumkanal-alpha-untereinheitsvarianten - Google Patents
Natriumkanal-alpha-untereinheitsvariantenInfo
- Publication number
- ATE423139T1 ATE423139T1 AT03767086T AT03767086T ATE423139T1 AT E423139 T1 ATE423139 T1 AT E423139T1 AT 03767086 T AT03767086 T AT 03767086T AT 03767086 T AT03767086 T AT 03767086T AT E423139 T1 ATE423139 T1 AT E423139T1
- Authority
- AT
- Austria
- Prior art keywords
- variants
- sodium channel
- subunity
- channel alpha
- present
- Prior art date
Links
- 108010052164 Sodium Channels Proteins 0.000 title abstract 3
- 102000018674 Sodium Channels Human genes 0.000 title abstract 3
- 230000035772 mutation Effects 0.000 abstract 3
- 101000694017 Homo sapiens Sodium channel protein type 5 subunit alpha Proteins 0.000 abstract 2
- 102100027198 Sodium channel protein type 5 subunit alpha Human genes 0.000 abstract 2
- 241000282412 Homo Species 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000019622 heart disease Diseases 0.000 abstract 1
- 238000011269 treatment regimen Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compositions Of Oxide Ceramics (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Television Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40101802P | 2002-08-02 | 2002-08-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE423139T1 true ATE423139T1 (de) | 2009-03-15 |
Family
ID=31495913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03767086T ATE423139T1 (de) | 2002-08-02 | 2003-08-01 | Natriumkanal-alpha-untereinheitsvarianten |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7485455B2 (de) |
| EP (1) | EP1572094B1 (de) |
| JP (1) | JP2006515504A (de) |
| AT (1) | ATE423139T1 (de) |
| AU (1) | AU2003265342A1 (de) |
| DE (1) | DE60326267D1 (de) |
| WO (1) | WO2004012668A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007098065A2 (en) * | 2006-02-17 | 2007-08-30 | The United States Of America As Represented By The Department Of Veterans Affairs | Human sodium channel isoforms |
| WO2009094218A2 (en) * | 2008-01-22 | 2009-07-30 | Chromocell Corporation | Novel cell lines expressing nav and methods using them |
| KR101857523B1 (ko) * | 2016-09-22 | 2018-05-14 | 가톨릭대학교 산학협력단 | Nav1.5를 안정적으로 발현하는 세포주 및 이를 이용한 약물 스크리닝 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5380836A (en) * | 1989-02-13 | 1995-01-10 | Arch Development Corporation | Nucleic acid encoding sodium channel protein |
| WO1996028537A1 (en) | 1995-03-09 | 1996-09-19 | University Of Utah Research Foundation | Long qt genes and method for diagnosing or preventing the occurrence of long qt syndrome |
| US5599673A (en) * | 1995-03-09 | 1997-02-04 | University Of Utah Research Foundation | Long QT syndrome genes |
| US5892018A (en) * | 1996-04-02 | 1999-04-06 | Welsh; Michael J. | DNA sequences encoding a brain sodium channel protein |
| US6030810A (en) * | 1997-02-26 | 2000-02-29 | Delgado; Stephen Gregory | Cloned tetrodotoxin-sensitive sodium channel α-subunit and a splice variant thereof |
| WO2002042842A2 (en) * | 2000-11-22 | 2002-05-30 | Allergan, Inc. | A high-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels |
-
2003
- 2003-08-01 WO PCT/US2003/024190 patent/WO2004012668A2/en not_active Ceased
- 2003-08-01 EP EP03767086A patent/EP1572094B1/de not_active Expired - Lifetime
- 2003-08-01 DE DE60326267T patent/DE60326267D1/de not_active Expired - Lifetime
- 2003-08-01 AT AT03767086T patent/ATE423139T1/de not_active IP Right Cessation
- 2003-08-01 JP JP2004526329A patent/JP2006515504A/ja active Pending
- 2003-08-01 AU AU2003265342A patent/AU2003265342A1/en not_active Abandoned
- 2003-08-01 US US10/632,342 patent/US7485455B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1572094B1 (de) | 2009-02-18 |
| AU2003265342A1 (en) | 2004-02-23 |
| WO2004012668A3 (en) | 2006-12-07 |
| EP1572094A2 (de) | 2005-09-14 |
| AU2003265342A8 (en) | 2004-02-23 |
| EP1572094A4 (de) | 2007-07-18 |
| US20040126787A1 (en) | 2004-07-01 |
| US7485455B2 (en) | 2009-02-03 |
| DE60326267D1 (de) | 2009-04-02 |
| WO2004012668A2 (en) | 2004-02-12 |
| JP2006515504A (ja) | 2006-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Währborg et al. | Nature-assisted rehabilitation for reactions to severe stress and/or depression in a rehabilitation garden: long-term follow-up including comparisons with a matched population-based reference cohort. | |
| Hooper et al. | Implant‐supported facial prostheses provided by a maxillofacial unit in a UK regional hospital: longevity and patient opinions | |
| BRPI0411539A (pt) | escova de dentes | |
| Hassel et al. | Oral health-related quality of life and depression/anxiety in long-term recurrence-free patients after treatment for advanced oral squamous cell cancer | |
| CY1114133T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ | |
| EA200700427A1 (ru) | Предупреждение и лечение синуклеинопатических и амилоидогенных заболеваний | |
| BR0207883A (pt) | Composições de medicamentos à base de anticolenérgicos e inibidores de pde-iv | |
| Baird et al. | Efficacy of guided imagery with relaxation for osteoarthritis symptoms and medication intake | |
| EP1543158A4 (de) | Regulierte aptamer-therapeutika | |
| MXPA05001010A (es) | Plantas de brassica oleracea resistentes a la enfermedad de la raiz deforme. | |
| BR0312446A (pt) | 2-heteroaril carboxamidas | |
| PA8571501A1 (es) | Inhibidores triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa | |
| BR0313413A (pt) | Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer | |
| BR0309122A (pt) | Plantas com morfogênese melhorada e método para sua construção | |
| NO20080781L (no) | GLEPP-inhibitorer i behandlingen av autoimmune og/eller inflammatoriske sykdommer | |
| JOP20230173A1 (ar) | أشطر إطالة العمر-النصفي وطرق استخدامها | |
| ATE423139T1 (de) | Natriumkanal-alpha-untereinheitsvarianten | |
| EP1589980A4 (de) | Verfahren zur diagnose und behandlung voninterstitieller lungenerkrankung | |
| DE10393745D2 (de) | Funktionelle Korrektur der ·-··7··8··6·C/T-Varianz des humanen eNOS-Gens | |
| DE602004009414D1 (de) | BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN MIT N-2,3,3-TETRAMETHYLBICYCLOi2.2.1öHEPTAN-2-AMINE | |
| DK1694271T3 (da) | FSH-glykosyleringsmutant | |
| DE60321175D1 (de) | Dichloracetat in kombination mit kardioprotektiven oder hämodynamischen medikamenten | |
| ID23184A (id) | Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi | |
| Hugo et al. | Acrodermatitis continua Hallopeau successfully treated by risankizumab. | |
| ITBO20030261A0 (it) | Unita'di irraggiamento luminoso per diagnosi e cura di problemi cutanei |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |